Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Apple warns of "mercenary spyware attack" in 92 countries

(Sharecast News) - Apple has reportedly sent threat notifications to iPhone users in 92 countries who may have been victims of a "mercenary spyware attack". According to numerous news outlets in India, a notification email sent by the tech giant to customers said that attackers have attempted to "remotely compromise the iPhone associated with your Apple ID".

It is unclear how many iPhone users have been targeted by the attacks, but the security notice on Apple's website says the vast majority of users will never be targeted by such attacks.

"Apple threat notifications are designed to inform and assist users who may have been individually targeted by mercenary spyware attacks, likely because of who they are or what they do," the security notice on Apple's website said.

"Such attacks are vastly more complex than regular cybercriminal activity and consumer malware, as mercenary spyware attackers apply exceptional resources to target a very small number of specific individuals and their devices."

Apple said that the cost, sophistication and global nature of mercenary spyware attacks "makes them some of the most advanced digital threats in existence today".

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.